In her paperwork, Ms. DeVos said her stake in Theranos was valued at more than $1 million.
Theranos has drawn scrutiny from CMS and the FDA. The company has been sued multiple times over faulty blood tests, and federal prosecutors launched an investigation into the company in 2016 over allegations it misled investors by misrepresenting the readiness of its technologies and operations.
Ms. DeVos reported income from her Theranos holdings at less than $201.
More articles on healthcare finance:
5 latest hospital bankruptcies
Northwestern Memorial HealthCare’s operating income jumps 87%
